Tirzepatide has emerged as a groundbreaking treatment option for individuals seeking effective weight loss. As a dual-acting medication, it simultaneously targets both glucagon and insulin, leading to improved blood sugar control associated with obesity. Clinical trials have demonstrated impressive outcomes with tirzepatide, showing considerable we